Almac is introducing a Next Generation Sequencing (NGS) service for personalised medicine. The company already carry out NGS work for bioinformatics company, Omixon, providing high quality data to complement their DNA analysis software.
Almac introduce a new mobile friendly website to enable customers and potential clients to browse their pharmaceutical and biotech services.
Almac adds new cGMP compliant encapsulation technology - a Bosch GKF 702 capsule filler featuring a KKE 1700 checkweigher - to extend their capsule filling and weighing capabilities.
Almac offer next generation sequencing (NGS) data analysis services supporting clients with everything from study design to sample preparation and DNA/RNA data analysis.
Almac's growing biocatalyst group expands their services in chiral building block supply, metabolite synthesis and commercial manufacturing.
Almac joins Merck KGaA and the MRC to investigate potential markers of response to Cetuximab therapy.
Almac complete a £9 million upgrade to their pharma services laboratory facilities, with a new three-storey extension to their existing production facilities.
Almac attended the BIO 2010 convention to announce the extension of PEGylation technology to single domain antibody fragments.
Contract manufacturing company, Almac, enter an industrial / academic collaboration with University College Cork to develop new technologies in Solid State Chemistry.
Almac gains a UK Great Place to Work® award in recognition of their commitment to the hiring and retention of inspirational people.